Bringing Cutting-Edge EV Isolation and Analysis Systems to Japan to Revolutionize EV Research
October 14, 2025
Auxor LLC (Headquarters: Hongo, Tokyo), and Everest Biolabs Inc., a global leader in the extracellular vesicles (EV) market, today announced an exclusive distribution agreement for Everest Biolabs’ products in Japan.
Auxor provides Japanese researchers with access to Everest Biolabs’s cutting edge platforms of Apex, Ascent, Summit, and Atlas, which offer scalable solutions for the isolation, purification, and quantification of extracellular vesicles. Through the partnership with Everest Biolabs, Auxor aims to contribute to the further development of EV research in Japan and the advancement of the life science field.
Everest Biolabs has been leading the global EV market with its innovative product lineup, primarily in the US and Europe. Their main products include the Ascent EV Automated Separation System, which enables high-throughput EV isolation, the Apex family of high performance EV isolation SEC columns, and the Atlas ELISA System for EV quantification, which enables multi-parameter analysis, dramatically improving the efficiency and accuracy of EV research.
Auxor will unveil its flagship products, including the Ascent and Apex, for the first time in Japan at JSEV2025 (the 12th Annual Meeting of the Japanese Society for Extracellular Vesicles), which will be held on Tuesday, October 14th and Wednesday, October 15th, 2025.
“We are excited to partner with Auxor to provide our solutions to Japan EV researchers,” said George Daaboul, CEO of Everest Biolabs. “Scalable solutions for extracellular vesicle isolation and characterization is the next step in precision nanomedicine, and our goal is to enable researchers to unlock new discoveries with our solutions.”
The Ascent, Apex, Atlas, and Summits platforms are designed For Research Use Only. It is not for use in diagnostic procedures.
About Everest Biolabs, Inc.
Everest Biolabs, founded on technology from the Wyss Institute, is dedicated to reaching excellence in EV research through the relentless focus on high-quality, easy-to-use tools for EV isolation and analytics. Our solutions enhance workflows, from foundational EV isolation to advanced analytics, enabling groundbreaking discoveries. With a vision to unlock the potential of EVs in clinical applications, we keep ‘science first’ while fostering innovation and integrity in everything we do. Based near Boston, MA we’re here to elevate exosome research at every step. Learn more at everestbiolabs.com.
About Auxor LLC
Established in 2025, Auxor, LLC is focused on solutions for EV researchers in Japan. The company’s team of highly trained sales and technical service professionals offers distribution partners sales and after-sales technical support, providing the highest level of product knowledge and expertise to academic and industrial scientists in EV research. Learn more at auxor.co.jp.
